Shift work that interferes with preferred sleep timing may increase risk of type 2 diabetes
29-6-2015 • Vetter C et al., Diabetes Care 2015
Type of shift work affects the risk of type 2 diabetes, depending on whether someone is an early vs. late chronotype. When the preferred sleep timing is disrupted, risk of T2DM may increase.
News • 25-6-2015
Consensus paper on arrhythmia management from a patient preference perspective
European and international experts reviewed the evidence on patient values and preferences in the management of cardiac tachyarrhythmias and advise on best practice.
Physical activity can lower PCSK9 levels in 3 months time
24-6-2015 • Kamani et al., Eur J Clin Invest. 2015
Promoting to use the stairs instead of the elevator during 3 months lowered PCSK9 levels in a healthy population, implying that small lifestyle changes can improve PCSK9 levels.
News • 15-6-2015
Sleep quality affects risk of heart attack and stroke
According to results from the WHO MONICA study, poor sleep should be considered a risk factor for cardiovascular disease along with smoking, lack of exercise and poor diet.
News • 24-5-2015
Heart failure patients with depression have five-fold increased mortality risk
Moderate to severe depression is strongly associated with death during the year following discharge after admission for exacerbation of heart failure, irrespective of the severity of heart failure or the presence of comorbidities.
Digoxin treatment possibly harmful, particularly when used to treat atrial fibrillation
6-5-2015 • Vamos et al., Eur Heart J. 2015
Large meta-analysis indicates that digoxin treatment is associated with higher all-cause mortality risk in patients with atrial fibrillation and with congestive heart failure.
News • 27-6-2015
EPCCS consensus guidance on stroke prevention in atrial fibrillation (SPAF) in primary care
General practitioners representing various European countries discussed recent developments in the SPAF field, and specific implications for primary care in an expert meeting. This meeting resulted in a practical guidance for European GPs.
Fewer heart failure hospitalisations with statins as primary or secondary prevention
24-6-2015 • Preiss D et al., Eur Heart J 2015
In primary and secondary prevention trials, statins lowered risk of the composite of non-fatal hospitalisation and HF death by ~10%, mostly driven by a fewer non-fatal hospitalisations.
News • 16-6-2015
Seeing your own calcified coronary arteries as a motivation to improve lifestyle
Patients with newly diagnosed coronary artery disease who looked at images of their own calcified coronary arteries were more likely to stop smoking, lose weight and take statins.
Non-statin drug also lowers LDL-c and CV events, even below target LDL-c levels
8-6-2015 • Cannon et al., NEJM 2015
The IMPROVE-IT trial shows that lowering LDL-c with addition of the cholesterol absorption inhibitor ezetimibe to simvastatin further lowers CV events, in ACS patients with LDL-c levels within recommendations.
News • 11-5-2015
Public awareness about heart failure is too low considering that one in five persons may be affected
European Heart Failure Awareness Day aims to educate the public about the severity of heart failure and the need to prevent and recognise it.
Type 2 diabetes incidence increases with higher intake of sugary drinks
4-5-2015 • O’Connor et al., Diabetologia 2015
Lowering consumption of sweet beverages such as soft drinks and sweetened-milk beverages and substitution with water and unsweetened tea or coffee may help lower the incidence of T2DM.
EPCCS 8th Annual Scientific Meeting
September 17-18, 2015 , Prague, Czech Republic
20th WONCA Europe Conference
22 - 25 oktober 2015, Istanbul, Turkey
All upcoming meetings...
Meeting reports & resources
Report of 7th Annual EPCCS meeting held in Brussels.
Report of 6th Annual EPCCS meeting held in London
Report of 5th Annual EPCCS meeting held in Athens
Report of 4th Annual EPCCS meeting held in Berlin
All meeting reports...